Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.56M
4 trades · 1 insiders
Net · 90d
$-1.56M
Insiders on file
35
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Michaelson Jennifer | See Remarks | 108 | $0 | $5.60M | 2026-09-08 |
| SUMER JACQUELYN L | Chief Legal Officer | 20 | $0 | $235.6K | 2026-06-30 |
| Fenton Mary Kay | Chief Financial Officer | 8 | $0 | $59.9K | 2026-06-30 |
| Doyle Mittie | Director | 2 | $0 | $0 | 2026-06-16 |
| Meek David D. | Director | 3 | $0 | $0 | 2026-06-16 |
| Rosenberg Anthony | Director | 6 | $0 | $0 | 2026-06-16 |
| Webster Stephen W | Director | 6 | $0 | $0 | 2026-06-16 |
| Allen Andrew R | Director | 2 | $0 | $0 | 2026-06-16 |
| Thistle Mary | Director | 2 | $0 | $0 | 2026-06-16 |
| Jones Jeffrey Alan | Chief Medical Officer | 19 | $0 | $309.6K | 2026-02-24 |
| AHMED NADIM | President and CEO | 21 | $100.3K | $794.2K | 2026-02-24 |
| Savill Corrine | Chief Business Officer | 27 | $0 | $2.54M | 2026-02-18 |
| Nichols Weston | 10% Owner | 1 | $1.39M | $0 | 2025-10-28 |
| Lynx1 Capital Management LP | 10% Owner | 7 | $11.93M | $0 | 2025-10-17 |
| Ryan David P. | Director | 3 | $0 | $0 | 2025-06-12 |
| Martin Anne-Marie | Director | 4 | $0 | $0 | 2025-06-12 |
| Ebeling Thomas | Director | 9 | $0 | $0 | 2024-06-10 |
| Trigilio Jeffrey | Chief Financial Officer | 28 | $47.3K | $689.7K | 2024-02-22 |
| Baeuerle Patrick | See Remarks | 11 | $0 | $610.0K | 2023-02-17 |
| BVF II GP LLC | Other | 8 | $2.97M | $0 | 2023-01-19 |
| Jovan-Embiricos Morana | Director | 10 | $0 | $711.9K | 2022-08-04 |
| F2 Bioscience I 2017 Ltd | 10% Owner | 3 | $0 | $1.30M | 2022-06-23 |
| GADICKE ANSBERT | Director, 10% Owner | 56 | $6.30M | $8.85M | 2022-06-22 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 3 | $8.27M | $0 | 2022-06-01 |
| F2 Vision SCS | 10% Owner | 4 | $0 | $4.05M | 2022-05-16 |
| BVF INC/IL | 10% Owner | 5 | $10.06M | $0 | 2022-05-13 |
| Zawel Leigh | See Remarks | 19 | $0 | $4.65M | 2022-02-11 |
| Keane Raymond T | Chief Legal Officer | 3 | $0 | $0 | 2022-02-11 |
| MPM Oncology Impact Management LP | 10% Owner | 18 | $6.30M | $2.59M | 2021-09-16 |
| UBS Oncology Impact Fund L.P. | 10% Owner | 4 | $0 | $717.2K | 2021-09-02 |
| Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | 5 | $0 | $4.40M | 2021-08-30 |
| MPM Oncology Impact Management GP LLC | 10% Owner | 1 | $0 | $72.9K | 2021-08-11 |
| F2 MG Ltd | 10% Owner | 20 | $4.20M | $0 | 2021-01-12 |
| Hughes Owen | President and CEO | 2 | $52.5K | $0 | 2021-01-12 |
| Wigginton Jon Marc | Chief Medical Officer | 1 | $0 | $0 | 2021-01-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-09-08 | 2026-09-10 | 4,000 | — | $0 | 78,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-09-08 | 2026-09-10 | 4,000 | $4.30 | $17.2K | 166,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-09-08 | 2026-09-10 | 8,000 | $21.57 | $172.6K | 158,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-09-08 | 2026-09-10 | 4,000 | — | $0 | 78,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-09-08 | 2026-09-10 | 8,000 | $21.57 | $172.6K | 158,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-09-08 | 2026-09-10 | 4,000 | $4.30 | $17.2K | 166,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-08-13 | 2026-08-14 | 30,000 | — | $0 | 82,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-08-13 | 2026-08-14 | 30,000 | $20.26 | $607.8K | 162,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-08-13 | 2026-08-14 | 30,000 | $4.30 | $129.0K | 192,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-08-13 | 2026-08-14 | 30,000 | — | $0 | 82,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-08-13 | 2026-08-14 | 30,000 | $20.26 | $607.8K | 162,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-08-13 | 2026-08-14 | 30,000 | $4.30 | $129.0K | 192,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-07-06 | 2026-07-07 | 4,000 | — | $0 | 112,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-07-06 | 2026-07-07 | 4,000 | $4.30 | $17.2K | 170,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-07-06 | 2026-07-07 | 8,000 | $17.82 | $142.6K | 162,844 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award | 2026-06-30 | 2026-07-02 | 1,541 | $8.60 | $13.3K | 127,921 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award | 2026-06-30 | 2026-07-02 | 2,470 | $8.60 | $21.2K | 130,559 | SEC↗ |
| Doyle Mittie | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 21,781 | — | $0 | 21,781 | SEC↗ |
| Thistle Mary | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 25,319 | — | $0 | 25,319 | SEC↗ |
| Allen Andrew R | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 21,781 | — | $0 | 21,781 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 25,319 | — | $0 | 25,319 | SEC↗ |
| Meek David D. | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 25,319 | — | $0 | 25,319 | SEC↗ |
| Rosenberg Anthony | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 25,319 | — | $0 | 25,319 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-05-05 | 2026-05-06 | 4,000 | — | $0 | 116,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-05-05 | 2026-05-06 | 4,000 | $4.30 | $17.2K | 174,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-05-05 | 2026-05-06 | 7,800 | $14.60 | $113.9K | 167,044 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-05-05 | 2026-05-06 | 200 | $15.58 | $3.1K | 166,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-03-05 | 2026-03-09 | 4,000 | — | $0 | 120,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-03-05 | 2026-03-09 | 8,000 | $15.68 | $125.4K | 170,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-03-05 | 2026-03-09 | 4,000 | $4.30 | $17.2K | 178,844 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-02-25 | 2026-02-26 | 1,780 | $14.14 | $25.2K | 174,844 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2026-02-24 | 2026-02-25 | 3,601 | $14.47 | $52.1K | 128,089 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2026-02-24 | 2026-02-25 | 4,582 | $14.47 | $66.3K | 159,968 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2026-02-24 | 2026-02-25 | 13,515 | $14.47 | $195.6K | 390,803 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-02-24 | 2026-02-25 | 3,601 | $14.47 | $52.1K | 176,624 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-02-23 | 2026-02-25 | 1,752 | $13.99 | $24.5K | 180,225 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2026-02-20 | 2026-02-23 | 8,000 | — | $0 | 124,987 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2026-02-20 | 2026-02-23 | 16,381 | $13.62 | $223.1K | 404,318 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2026-02-20 | 2026-02-23 | 3,742 | $13.62 | $51.0K | 131,690 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-02-20 | 2026-02-23 | 3,742 | $13.62 | $51.0K | 181,977 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2026-02-20 | 2026-02-23 | 8,000 | $4.30 | $34.4K | 189,977 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-02-20 | 2026-02-23 | 8,000 | $14.30 | $114.4K | 181,977 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2026-02-20 | 2026-02-23 | 4,982 | $13.62 | $67.9K | 164,550 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | S Sale | 2026-02-20 | 2026-02-23 | 4,398 | $13.62 | $59.9K | 126,380 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award deriv | 2026-02-18 | 2026-02-19 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award deriv | 2026-02-18 | 2026-02-19 | 137,500 | — | $0 | 137,500 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award deriv | 2026-02-18 | 2026-02-19 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AHMED NADIM | President and CEO | A Award deriv | 2026-02-18 | 2026-02-19 | 828,000 | — | $0 | 828,000 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award deriv | 2026-02-18 | 2026-02-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award deriv | 2026-02-18 | 2026-02-19 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award | 2026-02-18 | 2026-02-19 | 57,500 | — | $0 | 185,719 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award | 2026-02-18 | 2026-02-19 | 68,750 | — | $0 | 130,778 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-02-12 | 2026-02-13 | 416 | $12.03 | $5.0K | 128,219 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2026-01-22 | 2026-01-23 | 4,000 | $12.30 | $49.2K | 128,635 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award | 2025-12-31 | 2026-01-05 | 27 | $6.49 | $175 | 62,028 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2025-12-23 | 2025-12-29 | 9,922 | $10.01 | $99.3K | 420,699 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-12-19 | 2025-12-22 | 1,345 | $10.01 | $13.5K | 132,635 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-12-18 | 2025-12-19 | 2,898 | $9.67 | $28.0K | 133,980 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2025-12-18 | 2025-12-19 | 4,632 | $9.67 | $44.8K | 169,532 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2025-12-18 | 2025-12-19 | 3,480 | $9.67 | $33.7K | 135,432 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-12-15 | 2025-12-16 | 995 | $11.90 | $11.8K | 136,878 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-12-12 | 2025-12-16 | 2,148 | $12.38 | $26.6K | 137,873 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-11-24 | 2025-11-25 | 4,000 | $12.30 | $49.2K | 138,004 | SEC↗ |
| Nichols Weston | 10% Owner | P Buy | 2025-10-28 | 2025-10-30 | 165,667 | $8.40 | $1.39M | 8,963,500 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-17 | 2025-10-21 | 32,217 | $7.84 | $252.6K | 8,797,833 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-16 | 2025-10-21 | 150,000 | $8.86 | $1.33M | 8,765,616 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-15 | 2025-10-21 | 51,500 | $7.94 | $408.9K | 8,615,616 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-14 | 2025-10-21 | 15,032 | $7.59 | $114.1K | 8,564,116 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-10 | 2025-10-10 | 277,298 | $7.36 | $2.04M | 8,549,084 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-09 | 2025-10-10 | 626,043 | $6.70 | $4.19M | 8,271,786 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-10-08 | 2025-10-10 | 556,300 | $6.46 | $3.59M | 7,645,743 | SEC↗ |
| Doyle Mittie | Director | A Award deriv | 2025-08-07 | 2025-08-08 | 79,456 | — | $0 | 79,456 | SEC↗ |
| Allen Andrew R | Director | A Award deriv | 2025-08-07 | 2025-08-08 | 79,456 | — | $0 | 79,456 | SEC↗ |
| Martin Anne-Marie | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 38,513 | — | $0 | 38,513 | SEC↗ |
| Meek David D. | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 38,513 | — | $0 | 38,513 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 38,513 | — | $0 | 38,513 | SEC↗ |
| Rosenberg Anthony | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 38,513 | — | $0 | 38,513 | SEC↗ |
| Ryan David P. | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 38,513 | — | $0 | 38,513 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2025-02-25 | 2025-02-27 | 3,756 | $8.53 | $32.0K | 136,895 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2025-02-25 | 2025-02-27 | 12,529 | $8.53 | $106.9K | 430,621 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-02-25 | 2025-02-27 | 3,756 | $8.53 | $32.0K | 142,004 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2025-02-25 | 2025-02-27 | 4,895 | $8.53 | $41.8K | 174,164 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award deriv | 2025-02-19 | 2025-02-21 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award deriv | 2025-02-19 | 2025-02-21 | 130,000 | — | $0 | 130,000 | SEC↗ |
| AHMED NADIM | President and CEO | A Award deriv | 2025-02-19 | 2025-02-21 | 360,000 | — | $0 | 360,000 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award deriv | 2025-02-19 | 2025-02-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award deriv | 2025-02-19 | 2025-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award deriv | 2025-02-19 | 2025-02-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award | 2025-02-19 | 2025-02-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award | 2025-02-19 | 2025-02-21 | 65,000 | — | $0 | 179,059 | SEC↗ |
| AHMED NADIM | President and CEO | A Award | 2025-02-19 | 2025-02-21 | 180,000 | — | $0 | 443,150 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award | 2025-02-19 | 2025-02-21 | 50,000 | — | $0 | 140,651 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award | 2025-02-19 | 2025-02-21 | 37,500 | — | $0 | 240,990 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award | 2025-02-19 | 2025-02-21 | 50,000 | — | $0 | 145,760 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2025-01-06 | 2025-01-07 | 4,000 | $12.51 | $50.0K | 95,760 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2024-12-24 | 2024-12-27 | 8,400 | $11.87 | $99.7K | 263,150 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2024-12-18 | 2024-12-20 | 4,632 | $11.41 | $52.9K | 114,059 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2024-12-18 | 2024-12-20 | 3,482 | $11.41 | $39.7K | 90,651 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-12-18 | 2024-12-20 | 4,693 | $11.41 | $53.5K | 99,760 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-12-12 | 2024-12-16 | 3,489 | $12.52 | $43.7K | 104,453 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-11-05 | 2024-11-07 | 8,000 | $15.64 | $125.1K | 107,942 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-09-05 | 2024-09-09 | 8,000 | $18.09 | $144.7K | 115,942 | SEC↗ |
| Thistle Mary | Director | A Award deriv | 2024-08-08 | 2024-08-09 | 25,743 | — | $0 | 25,743 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-07-05 | 2024-07-09 | 8,000 | $16.33 | $130.6K | 123,942 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award | 2024-07-01 | 2024-07-02 | 2,360 | $9.00 | $21.2K | 131,942 | SEC↗ |
| Ryan David P. | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 15,806 | — | $0 | 15,806 | SEC↗ |
| Martin Anne-Marie | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 15,806 | — | $0 | 15,806 | SEC↗ |
| Rosenberg Anthony | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 15,806 | — | $0 | 15,806 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 15,806 | — | $0 | 15,806 | SEC↗ |
| Ebeling Thomas | Director | M Exercise deriv | 2024-06-10 | 2024-06-11 | 18,450 | — | $0 | 0 | SEC↗ |
| Ebeling Thomas | Director | M Exercise | 2024-06-10 | 2024-06-11 | 18,450 | $13.00 | $239.8K | 186,653 | SEC↗ |
| Ebeling Thomas | Director | M Exercise deriv | 2024-05-23 | 2024-05-23 | 16,475 | — | $0 | 0 | SEC↗ |
| Ebeling Thomas | Director | M Exercise deriv | 2024-05-23 | 2024-05-23 | 84,224 | — | $0 | 0 | SEC↗ |
| Ebeling Thomas | Director | A Award | 2024-05-23 | 2024-05-23 | 16,475 | $12.73 | $209.7K | 168,203 | SEC↗ |
| Ebeling Thomas | Director | A Award | 2024-05-23 | 2024-05-23 | 84,224 | $4.30 | $362.2K | 151,728 | SEC↗ |
| Meek David D. | Director | A Award deriv | 2024-05-15 | 2024-05-16 | 15,618 | — | $0 | 15,618 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2024-05-07 | 2024-05-08 | 5,606 | — | $0 | 132,987 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-05-07 | 2024-05-08 | 5,606 | $30.06 | $168.5K | 129,582 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2024-05-07 | 2024-05-08 | 5,606 | $4.30 | $24.1K | 135,188 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise deriv | 2024-05-06 | 2024-05-08 | 50,000 | — | $0 | 138,593 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | M Exercise | 2024-05-06 | 2024-05-08 | 50,000 | $4.30 | $215.0K | 187,582 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-05-06 | 2024-05-08 | 20,277 | $28.54 | $578.7K | 129,582 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2024-05-06 | 2024-05-08 | 37,723 | $27.82 | $1.05M | 149,859 | SEC↗ |
| Fenton Mary Kay | Chief Financial Officer | A Award deriv | 2024-04-29 | 2024-04-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award deriv | 2024-02-22 | 2024-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award deriv | 2024-02-22 | 2024-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award deriv | 2024-02-22 | 2024-02-23 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award deriv | 2024-02-22 | 2024-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award deriv | 2024-02-22 | 2024-02-23 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AHMED NADIM | President and CEO | A Award deriv | 2024-02-22 | 2024-02-23 | 320,000 | — | $0 | 320,000 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award | 2024-02-22 | 2024-02-23 | 50,000 | — | $0 | 94,133 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | A Award | 2024-02-22 | 2024-02-23 | 50,000 | — | $0 | 137,582 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award | 2024-02-22 | 2024-02-23 | 62,500 | — | $0 | 118,691 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award | 2024-02-22 | 2024-02-23 | 50,000 | — | $0 | 133,919 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award | 2024-02-22 | 2024-02-23 | 37,500 | — | $0 | 203,490 | SEC↗ |
| AHMED NADIM | President and CEO | A Award | 2024-02-22 | 2024-02-23 | 160,000 | — | $0 | 271,550 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise deriv | 2024-02-01 | 2024-02-02 | 40,000 | — | $0 | 70,331 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise | 2024-02-01 | 2024-02-02 | 40,000 | $4.30 | $172.0K | 205,990 | SEC↗ |
| Savill Corrine | Chief Business Officer | S Sale | 2024-02-01 | 2024-02-02 | 40,000 | $16.18 | $647.2K | 165,990 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise deriv | 2024-01-29 | 2024-01-30 | 13,997 | — | $0 | 0 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise deriv | 2024-01-29 | 2024-01-30 | 26,003 | — | $0 | 110,331 | SEC↗ |
| Savill Corrine | Chief Business Officer | S Sale | 2024-01-29 | 2024-01-30 | 40,000 | $14.09 | $563.6K | 165,990 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise | 2024-01-29 | 2024-01-30 | 40,000 | $4.30 | $172.0K | 205,990 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise deriv | 2024-01-23 | 2024-01-24 | 21,316 | — | $0 | 13,997 | SEC↗ |
| Savill Corrine | Chief Business Officer | S Sale | 2024-01-23 | 2024-01-24 | 21,316 | $12.46 | $265.6K | 165,990 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise | 2024-01-23 | 2024-01-24 | 21,316 | $4.30 | $91.7K | 187,306 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise deriv | 2024-01-22 | 2024-01-24 | 14,559 | — | $0 | 35,313 | SEC↗ |
| Savill Corrine | Chief Business Officer | S Sale | 2024-01-22 | 2024-01-24 | 4,125 | $12.02 | $49.6K | 165,990 | SEC↗ |
| Savill Corrine | Chief Business Officer | S Sale | 2024-01-22 | 2024-01-24 | 14,559 | $12.18 | $177.3K | 170,115 | SEC↗ |
| Savill Corrine | Chief Business Officer | M Exercise | 2024-01-22 | 2024-01-24 | 14,559 | $4.30 | $62.6K | 184,674 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2023-12-26 | 2023-12-27 | 4,272 | $9.24 | $39.5K | 111,550 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2023-12-21 | 2023-12-22 | 1,145 | $8.50 | $9.7K | 87,582 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-12-21 | 2023-12-22 | 1,920 | $8.50 | $16.3K | 83,919 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2023-12-21 | 2023-12-22 | 1,400 | $8.50 | $11.9K | 44,133 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2023-12-21 | 2023-12-22 | 1,860 | $8.50 | $15.8K | 56,191 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-12-18 | 2023-12-20 | 398 | $8.22 | $3.3K | 85,839 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2023-12-18 | 2023-12-20 | 290 | $8.22 | $2.4K | 45,533 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2023-12-18 | 2023-12-20 | 386 | $8.22 | $3.2K | 58,051 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2023-12-18 | 2023-12-20 | 238 | $8.22 | $2.0K | 88,727 | SEC↗ |
| Michaelson Jennifer | Chief Scientific Officer | S Sale | 2023-12-12 | 2023-12-13 | 1,068 | $7.81 | $8.3K | 88,965 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-12-12 | 2023-12-13 | 1,926 | $7.81 | $15.0K | 86,237 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award | 2023-06-30 | 2023-07-05 | 2,340 | $9.08 | $21.2K | 88,163 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2023-06-28 | 2023-06-29 | 759 | $11.40 | $8.7K | 115,822 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2023-06-20 | 2023-06-21 | 291 | $12.94 | $3.8K | 45,823 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-06-20 | 2023-06-21 | 399 | $12.94 | $5.2K | 85,823 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-06-20 | 2023-06-21 | 238 | $12.94 | $3.1K | 90,033 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2023-06-20 | 2023-06-21 | 387 | $12.94 | $5.0K | 58,437 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-06-12 | 2023-06-14 | 176 | $13.11 | $2.3K | 90,271 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-06-12 | 2023-06-14 | 319 | $13.11 | $4.2K | 86,222 | SEC↗ |
| Martin Anne-Marie | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 18,450 | — | $0 | 18,450 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 18,450 | — | $0 | 18,450 | SEC↗ |
| Rosenberg Anthony | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 18,450 | — | $0 | 18,450 | SEC↗ |
| Ebeling Thomas | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 18,450 | — | $0 | 18,450 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise deriv | 2023-06-07 | 2023-06-08 | 100 | — | $0 | 188,593 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise | 2023-06-07 | 2023-06-08 | 100 | $4.30 | $430 | 90,547 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-06-07 | 2023-06-08 | 100 | $12.40 | $1.2K | 90,447 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise deriv | 2023-06-06 | 2023-06-08 | 11,900 | — | $0 | 188,693 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-06-06 | 2023-06-08 | 11,900 | $12.31 | $146.5K | 90,447 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise | 2023-06-06 | 2023-06-08 | 11,900 | $4.30 | $51.2K | 102,347 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2023-05-23 | 2023-05-24 | 707 | $9.15 | $6.5K | 116,581 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-05-18 | 2023-05-19 | 399 | $8.76 | $3.5K | 86,541 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2023-05-18 | 2023-05-19 | 291 | $8.76 | $2.5K | 46,114 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2023-05-18 | 2023-05-19 | 394 | $8.76 | $3.5K | 58,824 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-05-18 | 2023-05-19 | 239 | $8.76 | $2.1K | 90,447 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-05-12 | 2023-05-16 | 347 | $8.78 | $3.0K | 86,940 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-05-12 | 2023-05-16 | 193 | $8.78 | $1.7K | 90,686 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2023-04-25 | 2023-04-26 | 716 | $10.59 | $7.6K | 117,288 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2023-04-18 | 2023-04-20 | 290 | $10.71 | $3.1K | 46,405 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-04-18 | 2023-04-20 | 238 | $10.71 | $2.5K | 90,879 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-04-18 | 2023-04-20 | 398 | $10.71 | $4.3K | 87,287 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2023-04-18 | 2023-04-20 | 392 | $10.71 | $4.2K | 59,218 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-04-12 | 2023-04-14 | 176 | $10.22 | $1.8K | 91,117 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-04-12 | 2023-04-14 | 318 | $10.22 | $3.2K | 87,685 | SEC↗ |
| AHMED NADIM | President and CEO | S Sale | 2023-03-23 | 2023-03-27 | 706 | $10.51 | $7.4K | 118,004 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | S Sale | 2023-03-20 | 2023-03-27 | 305 | $11.32 | $3.5K | 46,695 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2023-03-20 | 2023-03-27 | 238 | $11.32 | $2.7K | 91,293 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | S Sale | 2023-03-20 | 2023-03-27 | 390 | $11.32 | $4.4K | 59,610 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2023-03-20 | 2023-03-27 | 399 | $11.32 | $4.5K | 88,003 | SEC↗ |
| AHMED NADIM | President and CEO | A Award deriv | 2023-02-22 | 2023-02-23 | 211,000 | — | $0 | 211,000 | SEC↗ |
| AHMED NADIM | President and CEO | A Award | 2023-02-22 | 2023-02-23 | 109,000 | — | $0 | 118,710 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award deriv | 2023-02-17 | 2023-02-21 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | A Award deriv | 2023-02-17 | 2023-02-21 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Baeuerle Patrick | Chief Scientific Officer | A Award deriv | 2023-02-17 | 2023-02-21 | 77,000 | — | $0 | 77,000 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award deriv | 2023-02-17 | 2023-02-21 | 93,500 | — | $0 | 93,500 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award deriv | 2023-02-17 | 2023-02-21 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award deriv | 2023-02-17 | 2023-02-21 | 93,500 | — | $0 | 93,500 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award | 2023-02-17 | 2023-02-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | A Award | 2023-02-17 | 2023-02-21 | 38,500 | — | $0 | 91,531 | SEC↗ |
| Baeuerle Patrick | Chief Scientific Officer | A Award | 2023-02-17 | 2023-02-21 | 38,500 | — | $0 | 76,000 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award | 2023-02-17 | 2023-02-21 | 47,000 | — | $0 | 47,000 | SEC↗ |
| Savill Corrine | Chief Business Officer | A Award | 2023-02-17 | 2023-02-21 | 20,500 | — | $0 | 170,115 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award | 2023-02-17 | 2023-02-21 | 47,000 | — | $0 | 88,402 | SEC↗ |
| BVF II GP LLC | Other | J Other deriv | 2023-01-19 | 2023-01-19 | 350,000 | — | $0 | 350,000 | SEC↗ |
| BVF II GP LLC | Other | J Other deriv | 2023-01-19 | 2023-01-19 | 260,000 | — | $0 | 260,000 | SEC↗ |
| BVF II GP LLC | Other | J Other deriv | 2023-01-19 | 2023-01-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BVF II GP LLC | Other | J Other | 2023-01-19 | 2023-01-19 | 3,500,000 | — | $0 | 558,854 | SEC↗ |
| BVF II GP LLC | Other | J Other | 2023-01-19 | 2023-01-19 | 2,600,000 | — | $0 | 392,808 | SEC↗ |
| BVF II GP LLC | Other | J Other | 2023-01-19 | 2023-01-19 | 300,000 | — | $0 | 64,161 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award | 2022-12-30 | 2023-01-06 | 201 | $8.97 | $1.8K | 41,402 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise deriv | 2022-11-25 | 2022-11-29 | 4,000 | — | $0 | 200,593 | SEC↗ |
| Michaelson Jennifer | See Remarks | S Sale | 2022-11-25 | 2022-11-29 | 4,000 | $13.30 | $53.2K | 53,031 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise | 2022-11-25 | 2022-11-29 | 4,000 | $4.30 | $17.2K | 57,031 | SEC↗ |
| Ryan David P. | Director | A Award deriv | 2022-11-01 | 2022-11-02 | 26,150 | — | $0 | 26,150 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise deriv | 2022-09-27 | 2022-09-29 | 4,000 | — | $0 | 204,593 | SEC↗ |
| Michaelson Jennifer | See Remarks | S Sale | 2022-09-27 | 2022-09-29 | 4,000 | $12.40 | $49.6K | 53,031 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise | 2022-09-27 | 2022-09-29 | 4,000 | $4.30 | $17.2K | 57,031 | SEC↗ |
| SUMER JACQUELYN L | Chief Legal Officer | A Award deriv | 2022-08-15 | 2022-08-16 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise deriv | 2022-08-08 | 2022-08-09 | 1,385 | — | $0 | 208,593 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise | 2022-08-08 | 2022-08-09 | 1,385 | $4.30 | $6.0K | 54,416 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2022-08-08 | 2022-08-09 | 1,385 | $15.01 | $20.8K | 53,031 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | S Sale | 2022-08-04 | 2022-08-04 | 25,989 | $14.31 | $371.9K | 1,255,963 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | S Sale | 2022-08-03 | 2022-08-04 | 19,129 | $14.24 | $272.4K | 1,281,952 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | S Sale | 2022-08-02 | 2022-08-04 | 4,792 | $14.10 | $67.6K | 1,301,081 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise deriv | 2022-07-25 | 2022-07-26 | 8,000 | — | $0 | 209,978 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | S Sale | 2022-07-25 | 2022-07-26 | 8,000 | $14.51 | $116.1K | 53,031 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | M Exercise | 2022-07-25 | 2022-07-26 | 8,000 | $4.30 | $34.4K | 61,031 | SEC↗ |
| Savill Corrine | Acting Chief Business Office | S Sale | 2022-07-19 | 2022-07-21 | 14,958 | $15.22 | $227.7K | 149,615 | SEC↗ |
| Savill Corrine | Acting Chief Business Office | S Sale | 2022-07-18 | 2022-07-21 | 5,042 | $15.06 | $75.9K | 164,573 | SEC↗ |
| Savill Corrine | Acting Chief Business Office | S Sale | 2022-07-11 | 2022-07-12 | 39,800 | $13.33 | $530.5K | 169,815 | SEC↗ |
| Savill Corrine | Acting Chief Business Office | S Sale | 2022-07-11 | 2022-07-12 | 200 | $13.85 | $2.8K | 169,615 | SEC↗ |
| AHMED NADIM | President and CEO | A Award | 2022-06-30 | 2022-07-05 | 1,620 | $10.90 | $17.7K | 9,710 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award | 2022-06-30 | 2022-07-05 | 1,451 | $10.90 | $15.8K | 41,201 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | A Award | 2022-06-30 | 2022-07-05 | 1,620 | $10.90 | $17.7K | 53,031 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | M Exercise deriv | 2022-06-24 | 2022-06-28 | 104,845 | — | $0 | 0 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | M Exercise deriv | 2022-06-24 | 2022-06-28 | 35,529 | — | $0 | 0 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | M Exercise | 2022-06-24 | 2022-06-28 | 35,529 | $4.30 | $152.8K | 252,881 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | M Exercise | 2022-06-24 | 2022-06-28 | 104,845 | $4.30 | $450.8K | 217,352 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | F Tax w/h | 2022-06-24 | 2022-06-28 | 45,078 | $13.39 | $603.6K | 207,803 | SEC↗ |
| F2 Bioscience I 2017 Ltd | 10% Owner | S Sale | 2022-06-23 | 2022-06-23 | 29,631 | $13.00 | $385.2K | 537,392 | SEC↗ |
| Rosenberg Anthony | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 16,475 | — | $0 | 16,475 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 16,475 | — | $0 | 16,475 | SEC↗ |
| GADICKE ANSBERT | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 16,475 | — | $0 | 16,475 | SEC↗ |
| Ebeling Thomas | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 16,475 | — | $0 | 16,475 | SEC↗ |
| F2 Bioscience I 2017 Ltd | 10% Owner | S Sale | 2022-06-22 | 2022-06-23 | 49,953 | $12.70 | $634.4K | 567,023 | SEC↗ |
| F2 Bioscience I 2017 Ltd | 10% Owner | S Sale | 2022-06-21 | 2022-06-23 | 22,319 | $12.77 | $285.0K | 616,976 | SEC↗ |
| AHMED NADIM | President and CEO | P Buy | 2022-06-06 | 2022-06-07 | 8,090 | $12.40 | $100.3K | 8,090 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2022-06-01 | 2022-06-03 | 405,641 | $11.00 | $4.46M | 4,058,854 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2022-06-01 | 2022-06-03 | 301,009 | $11.00 | $3.31M | 2,992,808 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2022-06-01 | 2022-06-03 | 44,746 | $11.00 | $492.2K | 364,161 | SEC↗ |
| F2 Vision SCS | 10% Owner | S Sale | 2022-05-16 | 2022-05-16 | 35,158 | $11.23 | $394.8K | 1,305,873 | SEC↗ |
| BVF INC/IL | 10% Owner | P Buy | 2022-05-13 | 2022-05-16 | 53,598 | $9.14 | $489.9K | 3,653,213 | SEC↗ |
| BVF INC/IL | 10% Owner | P Buy | 2022-05-13 | 2022-05-16 | 38,558 | $9.14 | $352.4K | 2,691,799 | SEC↗ |
| BVF INC/IL | 10% Owner | P Buy | 2022-05-13 | 2022-05-16 | 17,744 | $9.14 | $162.2K | 319,415 | SEC↗ |
| F2 Vision SCS | 10% Owner | S Sale | 2022-05-13 | 2022-05-16 | 34,189 | $10.48 | $358.3K | 1,341,031 | SEC↗ |
| F2 Vision SCS | 10% Owner | S Sale | 2022-05-13 | 2022-05-16 | 85,319 | $9.96 | $849.8K | 1,375,220 | SEC↗ |
| BVF INC/IL | 10% Owner | P Buy | 2022-05-12 | 2022-05-16 | 542,999 | $9.06 | $4.92M | 3,599,615 | SEC↗ |
| BVF INC/IL | 10% Owner | P Buy | 2022-05-12 | 2022-05-16 | 457,001 | $9.06 | $4.14M | 2,653,241 | SEC↗ |
| F2 Vision SCS | 10% Owner | S Sale | 2022-05-12 | 2022-05-16 | 264,072 | $9.25 | $2.44M | 1,460,539 | SEC↗ |
| BVF II GP LLC | Other | P Buy | 2022-04-01 | 2022-04-05 | 266,598 | $10.75 | $2.87M | 3,056,616 | SEC↗ |
| BVF II GP LLC | Other | P Buy | 2022-04-01 | 2022-04-05 | 9,402 | $10.75 | $101.1K | 2,196,240 | SEC↗ |
| AHMED NADIM | President and CEO | A Award deriv | 2022-03-05 | 2022-03-07 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Martin Anne-Marie | Director | A Award deriv | 2022-03-01 | 2022-03-02 | 36,880 | — | $0 | 36,880 | SEC↗ |
| Jones Jeffrey Alan | Chief Medical Officer | A Award deriv | 2022-02-28 | 2022-03-02 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award deriv | 2022-02-11 | 2022-02-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Savill Corrine | Acting Chief Business Office | A Award deriv | 2022-02-11 | 2022-02-15 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Zawel Leigh | See Remarks | A Award deriv | 2022-02-11 | 2022-02-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Baeuerle Patrick | See Remarks | A Award deriv | 2022-02-11 | 2022-02-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Keane Raymond T | Chief Legal Officer | A Award deriv | 2022-02-11 | 2022-02-15 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | A Award deriv | 2022-02-11 | 2022-02-15 | 57,000 | — | $0 | 57,000 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | A Award | 2022-02-11 | 2022-02-15 | 37,500 | — | $0 | 39,750 | SEC↗ |
| Savill Corrine | Acting Chief Business Office | A Award | 2022-02-11 | 2022-02-15 | 16,500 | — | $0 | 209,615 | SEC↗ |
| Zawel Leigh | See Remarks | A Award | 2022-02-11 | 2022-02-15 | 32,500 | — | $0 | 69,785 | SEC↗ |
| Baeuerle Patrick | See Remarks | A Award | 2022-02-11 | 2022-02-15 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Keane Raymond T | Chief Legal Officer | A Award | 2022-02-11 | 2022-02-15 | 22,500 | — | $0 | 24,124 | SEC↗ |
| Michaelson Jennifer | Chief Development Officer | A Award | 2022-02-11 | 2022-02-15 | 28,500 | — | $0 | 51,411 | SEC↗ |
| Jovan-Embiricos Morana | 10% Owner | J Other | 2022-01-11 | 2022-01-13 | 1,187,734 | — | $0 | 1,724,611 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise deriv | 2021-10-18 | 2021-10-20 | 4,000 | — | $0 | 217,978 | SEC↗ |
| AHMED NADIM | President and CEO | A Award deriv | 2021-10-18 | 2021-10-20 | 2,710,000 | — | $0 | 2,710,000 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise | 2021-10-18 | 2021-10-20 | 4,000 | $4.30 | $17.2K | 26,911 | SEC↗ |
| Michaelson Jennifer | See Remarks | S Sale | 2021-10-18 | 2021-10-20 | 3,396 | $21.10 | $71.7K | 23,515 | SEC↗ |
| Michaelson Jennifer | See Remarks | S Sale | 2021-10-18 | 2021-10-20 | 400 | $23.61 | $9.4K | 22,911 | SEC↗ |
| Michaelson Jennifer | See Remarks | S Sale | 2021-10-18 | 2021-10-20 | 204 | $22.40 | $4.6K | 23,311 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | M Exercise deriv | 2021-10-15 | 2021-10-18 | 8,000 | — | $0 | 229,891 | SEC↗ |
| Zawel Leigh | See Remarks | S Sale | 2021-10-15 | 2021-10-18 | 19,574 | $25.00 | $489.4K | 37,285 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | M Exercise | 2021-10-15 | 2021-10-18 | 8,000 | $4.30 | $34.4K | 10,250 | SEC↗ |
| Trigilio Jeffrey | Chief Financial Officer | S Sale | 2021-10-15 | 2021-10-18 | 8,000 | $25.00 | $200.0K | 2,250 | SEC↗ |
| Zawel Leigh | See Remarks | S Sale | 2021-10-07 | 2021-10-12 | 1,079 | $25.00 | $27.0K | 56,859 | SEC↗ |
| Michaelson Jennifer | See Remarks | M Exercise deriv | 2021-09-20 | 2021-09-21 | 4,000 | — | $0 | 221,978 | SEC↗ |
| Zawel Leigh | See Remarks | S Sale | 2021-09-20 | 2021-09-21 | 7,468 | $25.16 | $187.9K | 57,938 | SEC↗ |
| Michaelson Jennifer | See Remarks | S Sale | 2021-09-20 | 2021-09-21 | 3,200 | $24.34 | $77.9K | 23,711 | SEC↗ |